GOLDMAN SACHS GROUP INC - ASTRIA THERAPEUTICS INC ownership

ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 35 filers reported holding ASTRIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ASTRIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,595,820
+19.6%
395,145
+85.1%
0.00%0.0%
Q1 2024$3,005,491
+2289.7%
213,534
+1203.9%
0.00%
Q4 2023$125,768
-40.9%
16,376
-42.6%
0.00%
Q3 2023$212,833
-0.3%
28,530
+11.3%
0.00%
Q2 2023$213,523
-77.8%
25,633
-64.5%
0.00%
Q1 2023$959,688
+869.4%
72,157
+543.1%
0.00%
Q3 2021$99,00011,2210.00%
Other shareholders
ASTRIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TCG Crossover Management, LLC 5,278,928$74,300,9125.87%
Fairmount Funds Management LLC 3,554,129$50,024,3665.45%
Vivo Capital, LLC 2,329,027$32,781,0552.58%
VR Adviser, LLC 3,608,645$50,791,6782.42%
Tri Locum Partners LP 369,549$5,201,4021.80%
Sio Capital Management, LLC 410,267$5,774,5081.72%
Perceptive Advisors 6,485,420$91,249,8591.60%
Affinity Asset Advisors, LLC 845,606$11,901,9041.47%
Logos Global Management LP 1,244,960$17,522,8121.42%
Vestal Point Capital, LP 1,100,000$15,482,5001.28%
View complete list of ASTRIA THERAPEUTICS INC shareholders